Medical Science News

RSS

Human monoclonal antibody protects against SARS-CoV-2 and SARS-CoV in vivo

Scientists identified a human monoclonal antibody (mAb), which successfully neutralized or bound all sarbecoviruses tested in vitro.

16 Dec 2021

Exploring the plasma neutralization properties of the Omicron variant of SARS-CoV-2

A new study determines the ability of individuals with varying exposure to SARS-CoV-2 infection and vaccination, to neutralize SARS- CoV-2 pseudotypes.

16 Dec 2021

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

Researchers from Westmead Hospital have been investigating the effect of a third dose on neutralizing antibody titres in already vaccinated individuals.

16 Dec 2021

Vaccine effectiveness of mRNA-1273 during the emergence of the SARS-CoV-2 Delta variant

The authors highlight that their research confirms the effectiveness of two doses of mRNA-1273 against SARS-CoV-2 infection.

16 Dec 2021

Study explores how the female brain responds to genital touch

The exact location of the brain area representing genital touch varies among women. The new research in JNeurosci also found the region was thicker the more frequently the participants engaged in sexual intercourse.

16 Dec 2021

Evaluation of SARS-CoV-2 neutralizing antibodies in mothers and infants

A new study assessed nAb activities against five strains of SARS-CoV-2 in paired maternal and infant cord blood samples.

15 Dec 2021

Evaluation of SARS-CoV-2 Omicron's immune evasion potential

Researchers use VSV vector and Omicron spike protein containing all 32 mutations to create the pseudotyped SARS-CoV-2 Omicron variant (PV-Omicron).

15 Dec 2021

Signatures of rising SARS-CoV-2 Delta infections in New York

Researchers estimate the probability of breakthrough infections by the Delta variant as compared to other variants.

15 Dec 2021

First-of-its-kind gene therapy technique reverses severe hearing loss in mice

Hearing loss has been linked to mutations in at least 100 different genes, but up to 16 percent of genetic hearing loss can be traced to just one gene, STRC, the second most common genetic cause.

15 Dec 2021

Discovery can pave the way for new strategies to reduce atherosclerosis using omega-3 fatty acids

A receptor activated by substances formed from omega-3 fatty acids plays a vital role in preventing inflammation in blood vessels and reducing atherosclerosis, a new study from Karolinska Institutet in Sweden published in The Journal of Clinical Investigation reports.

15 Dec 2021

WVU researchers explore how a benign virus can be used to treat eye diseases

Viruses have a bad reputation for a good reason. But some viruses don't harm people. Some can even help them.

15 Dec 2021

Australian scientists discover an enzyme that is key to why exercise improves metabolic health

Monash University, Australia scientists have discovered an enzyme that is key to why exercise improves our health.

15 Dec 2021

Factors associated with having data on SARS-CoV-2 infection and COVID-19 severity

Researchers utilized pre-pandemic information from two UK-based observational population studies to investigate predictors of selection into analytic subsamples in observational studies on SARS-CoV-2 infection and on COVID-19 severity.

15 Dec 2021

T-cell immune response in previously infected and vaccinated individuals effective against SARS-CoV-2 Omicron variant

New findings illustrate that despite the continuous pattern of the ongoing evolution of SARS-CoV-2, it has not resulted in any significant accumulation of CD8+ T-cell escape mutations.

15 Dec 2021

Novel bioinformatics pipeline for fast and scalable analysis of large viral phylogenies

A team of researchers recently developed a bioinformatics approach to analyze viral phylogenetic clusters.

15 Dec 2021

Exploring the possibility of developing a plant-based oral vaccine against COVID-19

New research optimizes methods for the in-planta expression of the recombinant protein corresponding to the Receptor Binding Domain (RBD) subunit of the surface-exposed Spike glycoprotein of SARS-CoV-2.

15 Dec 2021

Receptor binding of SARS-CoV-2 Omicron variant compared to other variants

Researchers compared the binding of the new SARS-CoV-2 VOC Omicron’s RBD and ACE2 receptor with the original Wuhan SARS-CoV-2 strain and other VOCs such as Beta and Delta.

15 Dec 2021

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Researches have been investigating the possibility of using convalescent plasma to help patients recover from COVID-19.

15 Dec 2021

Persistence of symptoms up to a year after hospitalization for COVID-19

Researchers conducted a prospective cohort study to determine the persisting COVID-19 associated symptoms after hospitalization and their risk factors.

15 Dec 2021

Cell surface expression of SARS-CoV-2 nucleocapsid protein and its role in immunity

Researchers demonstrated the unexpected roles of nucleocapsid protein in innate and adaptive immunity to SARS-CoV-2.

15 Dec 2021

Medical Science News

Human monoclonal antibody protects against SARS-CoV-2 and SARS-CoV in vivo

Exploring the plasma neutralization properties of the Omicron variant of SARS-CoV-2

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

Vaccine effectiveness of mRNA-1273 during the emergence of the SARS-CoV-2 Delta variant

Study explores how the female brain responds to genital touch

Evaluation of SARS-CoV-2 neutralizing antibodies in mothers and infants

Evaluation of SARS-CoV-2 Omicron's immune evasion potential

Signatures of rising SARS-CoV-2 Delta infections in New York

First-of-its-kind gene therapy technique reverses severe hearing loss in mice

Discovery can pave the way for new strategies to reduce atherosclerosis using omega-3 fatty acids

WVU researchers explore how a benign virus can be used to treat eye diseases

Australian scientists discover an enzyme that is key to why exercise improves metabolic health

Factors associated with having data on SARS-CoV-2 infection and COVID-19 severity

T-cell immune response in previously infected and vaccinated individuals effective against SARS-CoV-2 Omicron variant

Novel bioinformatics pipeline for fast and scalable analysis of large viral phylogenies

Exploring the possibility of developing a plant-based oral vaccine against COVID-19

Receptor binding of SARS-CoV-2 Omicron variant compared to other variants

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Persistence of symptoms up to a year after hospitalization for COVID-19

Cell surface expression of SARS-CoV-2 nucleocapsid protein and its role in immunity

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News